Balyasny Asset Management’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$453K Sell
2,400
-4,400
-65% -$927K ﹤0.01% 2406
2025
Q4
$1.35M Buy
6,800
+5,700
+518% +$1.15M ﹤0.01% 2054
2025
Q3
$223K Sell
1,100
-18,900
-95% -$3.35M ﹤0.01% 2693
2025
Q2
$3.52M Buy
+20,000
New +$3.01M 0.01% 1464
2020
Q4
Sell
-50,000
Closed -$1.23M 1694
2020
Q3
$1.23M Buy
+50,000
New +$1.28M 0.01% 954

Other funds holding THC

Balyasny Asset Management's THC Position: Q1 2026 in Review

Balyasny Asset Management reduced its Tenet Healthcare (THC) stake by 99% in Q1 2026, selling an estimated $30M and leaving 1,163 shares worth $219K. The position accounts for ﹤0.01% of the portfolio, ranked #2667.

Balyasny Asset Management first reported a position in THC in Q2 2013 and has held it in 38 quarters since. The position peaked at $70.3M in Q3 2025. 691 funds tracked by Wall St. Rank hold THC as of Q1 2026.

  • Balyasny Asset Management held 1,163 shares of Tenet Healthcare worth $219K as of Q1 2026.
  • Balyasny Asset Management sold 142,551 Tenet Healthcare shares in Q1 2026, an estimated $30M.
  • Tenet Healthcare made up ﹤0.01% of Balyasny Asset Management's portfolio in Q1 2026, its #2667 holding.
  • Balyasny Asset Management first reported a position in Tenet Healthcare in Q2 2013 and has held it in 38 quarters since.
  • Balyasny Asset Management's Tenet Healthcare position peaked at $70.3M in Q3 2025.
  • 691 funds tracked by Wall St. Rank held Tenet Healthcare as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.